# Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

> **NCT00017082** · PHASE2 · COMPLETED · sponsor: **Prologue Research International**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00017082
- **Lead sponsor:** Prologue Research International
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2003-06
- **Final completion:** 2010-12
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017082, "Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00017082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*